{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:05:51Z","timestamp":1782774351094,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T00:00:00Z","timestamp":1661040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T00:00:00Z","timestamp":1661040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30901297"],"award-info":[{"award-number":["30901297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Doctoral Fund of Youth Scholars of Ministry of Education of China","award":["20090201120074"],"award-info":[{"award-number":["20090201120074"]}]},{"name":"Shaanxi Province She Fa","award":["2020SF-177"],"award-info":[{"award-number":["2020SF-177"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02380-w","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T18:02:22Z","timestamp":1661104942000},"page":"467-472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety of dupilumab in pediatric patients with moderate to severe atopic dermatitis: a real-world study"],"prefix":"10.1007","volume":"315","author":[{"given":"Dan-Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Wen","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8106-2358","authenticated-orcid":false,"given":"Xiao-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,21]]},"reference":[{"issue":"3","key":"2380_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2500\/aap.2012.33.3569","volume":"33","author":"SP DaVeiga","year":"2012","unstructured":"DaVeiga SP (2012) Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc [Internet] 33(3):227\u2013234","journal-title":"Allergy Asthma Proc [Internet]"},{"issue":"2","key":"2380_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.aller.2012.03.001","volume":"41","author":"J Mallol","year":"2013","unstructured":"Mallol J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A (2013) The International study of asthma and allergies in childhood (ISAAC) phase three: a global synthesis. Allergol Immunopathol 41(2):73\u201385","journal-title":"Allergol Immunopathol"},{"issue":"1","key":"2380_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/JD9.0000000000000143","volume":"4","author":"Xu Yao","year":"2021","unstructured":"Atopic Dermatitis Working Group IGCS of D, Yao Xu, Song Z-Q, Li W, Liang Y-S, Zhao Y et al (2021) Guidelines for diagnosis and treatment of atopic dermatitis in china (2020) #. Int J Dermatol Venerol 4(1):1\u20139","journal-title":"Int J Dermatol Venerol"},{"key":"2380_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jdin.2020.10.002","volume":"2","author":"K Urban","year":"2021","unstructured":"Urban K, Chu S, Giesey RL, Mehrmal S, Uppal P, Nedley N et al (2021) The global, regional, and national burden of atopic dermatitis in 195 countries and territories: an ecological study from the global burden of disease study 2017. JAAD Int 2:12\u201318","journal-title":"JAAD Int"},{"key":"2380_CR5","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) results; 2017. http:\/\/ghdx.healthdata. Accessed 1 May 2020"},{"issue":"10","key":"2380_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/1346-8138.15048","volume":"46","author":"TF Tsai","year":"2019","unstructured":"Tsai TF, Rajagopalan M, Chu CY, Encarnacion L, Gerber RA, Santos Estrella P et al (2019) Burden of atopic dermatitis in Asia. J Dermatol 46(10):825\u2013834","journal-title":"J Dermatol"},{"issue":"11","key":"2380_CR7","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1080\/14712598.2021.1907341","volume":"21","author":"M Napolitano","year":"2021","unstructured":"Napolitano M, Di Guida A, Nocerino M, Fabbrocini G, Patruno C (2021) The emerging role of dupilumab in dermatological indications. Expert Opin Biol Ther [Journal Article] 21(11):1461\u20131471","journal-title":"Expert Opin Biol Ther [Journal Article]"},{"key":"2380_CR8","unstructured":"Dupilumab [Prescribing Information] (2020) Regeneron Pharmaceuticals, Tarrytown. https:\/\/www.regeneron.com\/sites\/default\/files\/Dupixent_FPI.pdf. Accessed 16 June 2021."},{"key":"2380_CR9","unstructured":"https:\/\/www.nmpa.gov.cn\/zwfw\/sdxx\/sdxxyp\/yppjfb\/20210909162932132.html. Accessed 1 Dec 2021"},{"key":"2380_CR10","unstructured":"https:\/\/www.cde.org.cn\/main\/xxgk\/listpage\/2f78f372d351c6851af7431c7710a731. Accessed 1 Dec 2021"},{"issue":"2","key":"2380_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jdv.16928","volume":"35","author":"AS Paller","year":"2021","unstructured":"Paller AS, Siegfried EC, Simpson EL, Cork MJ, Lockshin B, Kosloski MP et al (2021) A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy. J Eur Acad Dermatol 35(2):464\u2013475","journal-title":"J Eur Acad Dermatol"},{"issue":"5","key":"2380_CR12","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jaad.2020.06.054","volume":"83","author":"AS Paller","year":"2020","unstructured":"Paller AS, Siegfried EC, Tha\u00e7i D, Wollenberg A, Cork MJ, Arkwright PD et al (2020) Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6\u201311\u00a0years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial. J AM Acad Dermatol 83(5):1282\u20131293","journal-title":"J AM Acad Dermatol"},{"issue":"6","key":"2380_CR13","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","volume":"132","author":"MS Lewis-Jones","year":"1995","unstructured":"Lewis-Jones MS, Finlay AY (1995) The children\u2019s dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol 132(6):942\u2013949","journal-title":"Br J Dermatol"},{"issue":"4","key":"2380_CR14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s13555-021-00543-7","volume":"11","author":"EL Simpson","year":"2021","unstructured":"Simpson EL, de Bruin-Weller M, Bansal A, Chen Z, Nelson L, Whalley D et al (2021) Definition of clinically meaningful within-patient changes in POEM and CDLQI in children 6 to 11 years of age with severe atopic dermatitis. Dermatol Ther 11(4):1415\u20131422","journal-title":"Dermatol Ther"},{"issue":"2","key":"2380_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13555-021-00505-z","volume":"11","author":"M Napolitano","year":"2021","unstructured":"Napolitano M, Ferrillo M, Patruno C, Scalvenzi M, Andrea MD, Fabbrocini G (2021) Efficacy and safety of dupilumab in clinical practice: one year of experience on 165 adult patients from a tertiary referral centre. Dermatol Ther 11(2):355\u2013361","journal-title":"Dermatol Ther"},{"issue":"2","key":"2380_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa1314768","volume":"371","author":"LA Beck","year":"2014","unstructured":"Beck LA, Tha\u00e7i D, Hamilton JD, Graham NM, Bieber T, Rocklin R et al (2014) Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. New Engl J Med 371(2):130\u2013139","journal-title":"New Engl J Med"},{"issue":"5","key":"2380_CR17","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/bjd.18041","volume":"181","author":"JC Armario-Hita","year":"2019","unstructured":"Armario-Hita JC, Pereyra-Rodriguez J, Silvestre JF, Ruiz-Villaverde R, Valero A, Izu-Belloso R et al (2019) Treatment of moderate-to-severe atopic dermatitiswith dupilumab in real clinical practice: a multicentre, retrospective case series. Br J Dermatol 181(5):1072\u20131074","journal-title":"Br J Dermatol"},{"key":"2380_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14282","author":"H Dakin","year":"2020","unstructured":"Dakin H, Haas C (2020) Successful and rapid clearance of severe, treatment-resistant atopic dermatitis with dupilumab in a3-year-old. Dermatol Ther. https:\/\/doi.org\/10.1111\/dth.14282","journal-title":"Dermatol Ther"},{"issue":"11","key":"2380_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jdcr.2019.08.023","volume":"5","author":"BA Varma","year":"2019","unstructured":"Varma BA, Tassavor M, Levitt J (2019) The utility of dupilumab for use in the pediatric population. JAAD Case Rep 5(11):943\u2013944","journal-title":"JAAD Case Rep"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02380-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02380-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02380-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T12:07:54Z","timestamp":1678968474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02380-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,21]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["2380"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02380-w","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,21]]},"assertion":[{"value":"5 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with provisions of the Declaration of Helsinki and International Conference on Harmonization guidelines for Good Clinical Practice. This study protocol was reviewed and approved by the Chinese Ethics Committee of Registering Clinical Trials (the approval number is ChiECRCT2021219).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consents to participate in the study were obtained from the participants or their parents\/legal guardians\/next of kin.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}